Press release
Ketlides Market Report 2024: Strategies And Recent Developments | Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG
Ketlides Market Trends
The Business Research Company offers in-depth market insights through Ketlides Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The ketlides market size has grown strongly in recent years. It will grow from $3.07 billion in 2023 to $3.22 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, growing consumption of antibiotics, demand for effective and convenient treatments for infectious diseases, government initiatives.
The ketlides market size is expected to see steady growth in the next few years. It will grow to $3.82 billion in 2028 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to investments in research and development activities for ketlides, growing number of screening programs for infectious diseases, incremental healthcare spending. growing awareness of antimicrobial stewardship. Major trends in the forecast period include innovative treatments for infectious diseases, development of targeted therapies, advancements in diagnosis and treatment of infectious diseases, development of new ketlide formulations.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12918&type=smp
Market Segmentation:
The main types of drugs included in ketlides are telithromycin, cethromycin and solithromycin. Telithromycin is a semi-synthetic antibiotic belonging to the ketlide class, used to treat respiratory tract infections. These are used to indicate various diseases, including bronchitis, pneumonia, sinusitis and tonsillitis or pharyngitis. Several types of microorganisms are involved, including streptococcus pneumoniae, haemophiles influenzae, moraxella catarrhalis, chlamydophila pneumoniae and mycoplasma pneumoniae and are sold through various distribution channels, such as hospital pharmacies, retail pharmacies, online pharmacies and others.
Ketlides Global Market Report 2023 provides data on the global ketlides market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors' revenues, profiles and market shares. The ketlides market report identifies opportunities and strategies based on market trends and leading competitors' approaches.
Major Driver - Rising Infectious Disease Prevalence Fuels Growth In The Ketlides Market
The increasing prevalence of infectious diseases is expected to propel the growth of the ketlides market going forward. Infectious diseases are illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites that can spread from person to person, resulting in a wide range of symptoms and health complications. Tuberculosis is one type of infectious disease. Ketlides, which are used in treating infectious diseases, have been evaluated for their potential use in treating tuberculosis as they exhibit high levels of intracellular activity, which play a significant role in treating tuberculosis. For instance, in October 2022, according to the Global Tuberculosis Report published by the World Health Organization, a Switzerland-based global health agency, there were an expected 10.6 million tuberculosis (TB) cases worldwide in 2021, a 4.5% rise from 10.1 million cases in 2020. Therefore, the increasing prevalence of infectious diseases is driving the growth of the ketgenic market.
Competitive Landscape:
Major players in the ketlides market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Shionogi & Company Limited, Dr. Reddys Laboratories Ltd., Taisho Pharmaceutical Co. Ltd., Glenmark Pharmaceuticals Ltd., Zhejiang Yongtai Technology Co. Ltd., Corden Pharma GmbH, Optimer Pharmaceuticals Inc., Vivimed Labs Limited, Wockhardt Ltd., Advanced Life Sciences Holdings Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/ketlides-global-market-report
Top Trend - Novel Drug Approval Paves The Way For Cethromycin's Versatile Application In Infectious Disease Treatment
Major companies operating in the ketlides market are focused on developing innovative drugs and treatments to gain competitive advantages and sustain their position in the market. For instance, in June 2023, AliquantumRx Inc., a US-based biotechnical research company, announced the approval of the United States Patent and Trademark Office (USPTO), a US-based agency in the Department of Commerce, for its patent 'salts and polymorphs of cethromycin for the treatment of bacterial and protozoan disease.' Cethromycin, a type of ketlide antibiotic, is effective against many infectious disorders caused by bacteria and protozoa, such as malaria, babesiosis, toxoplasmosis, diarrhea and others. This new patent will give the company more chances to score and lower the danger of cethromycin's commercialization by allowing it to be used for conditions other than malaria.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Ketlides Market Characteristics
3. Ketlides Market Trends And Strategies
4. Ketlides Market - Macro Economic Scenario
5. Ketlides Market Size And Growth
…..
27. Ketlides Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ketlides Market Report 2024: Strategies And Recent Developments | Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG here
News-ID: 3404246 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Ketlides
Antibiotic Animal Growth Promoters Market 2025: Industry Trends, Demand Insights …
Los Angeles, United State: QY Research has recently published a research report titled, "Global Antibiotic Animal Growth Promoters (AGPs) Market Research Report 2025". The global Antibiotic Animal Growth Promoters (AGPs) market is comprehensive and accurately presented in the report with the help of detailed market information and data, critical findings, error-free statistics, and reliable forecasts. The report digs deep into important aspects of the global Antibiotic Animal Growth Promoters (AGPs)…
